Coherus Biosciences Inc

NASDAQ:CHRS   10:05:16 AM EDT
18.12
+0.39 (+2.20%)
Products

Coherus And Junshi Biosciences Submit Rolling BLA To FDA For Nasopharyngeal Carcinoma Treatment

Published: 09/01/2021 12:17 GMT
Coherus Biosciences Inc (CHRS) - Coherus and Junshi Biosciences Announce Completion of Rolling Bla Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma.